// company-profile

Cullinan Therapeutics, Inc.

CGEM
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings121Insiders18
// api This Cullinan Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Doyle Mittie.

// 90-day insight

Over the last 90 days, Cullinan Therapeutics, Inc. insiders bought $17K across 8 transactions with no open-market sales.

  • Most active insider: Michaelson Jennifer with 4 transactions totaling $134K.
  • Largest single sale: $114K by Michaelson Jennifer on May 5, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Cullinan Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$885.5M
QoQ change
+45.5%
Reporting period
2026-03-31
#1
Lynx1 Capital Management LP
CIK 1910456
$127.4M
9.0M shares
#2
MPM BIOIMPACT LLC
CIK 1687078
$108.7M
7.6M shares
#3
BVF INC/IL
CIK 1056807
$81.7M
5.8M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026Doyle MittieCGEM
Award
21,781$0.00$0K
Jun 16, 2026Rosenberg AnthonyCGEM
Award
25,319$0.00$0K
Jun 16, 2026Webster Stephen WCGEM
Award
25,319$0.00$0K
Jun 16, 2026Allen Andrew RCGEM
Award
21,781$0.00$0K
Jun 16, 2026Thistle MaryCGEM
Award
25,319$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.